Add BrightSurf on Google Email

Loss of skin’s pigment-producing cells could be related to basement membrane disruption

Researchers from Osaka Metropolitan University have discovered that disruptions in the basement membrane zone between the epidermis and dermis could make it harder for pigment-producing cells to adhere. An enzyme called matrix metalloproteinase 2 (MMP2) may be overexpressed, leading to disturbance of the basement membrane.

SourceOsaka Metropolitan University·JournalThe Journal of Pathology·TypeExperimental study·DateSep 9, 2024

Breaking the trend: Skin cancer incidence in young adults declines

A new study found that skin cancer incidence in young adults declined in Sweden around 2015. The decrease in incidence and mortality is attributed to increased awareness of sun protection, reduced access to sunbeds, and changes in lifestyle habits such as spending more time indoors. The study suggests that continued emphasis on sun pro...

SourceKarolinska Institutet·JournalJAMA Dermatology·TypeObservational study·DateSep 8, 2024

Keeping skin healthy: New method provides molecular portrait of sebum production

Researchers developed a new method to map gene expression changes in sebocytes, providing insights into sebum production and its role in skin health. The study identifies key players in sebum production and suggests new ways to modulate it, with potential implications for acne, eczema, psoriasis, and infectious diseases.

SourceUniversität Leipzig·JournalJournal of Biological Chemistry·TypeExperimental study·DateJul 31, 2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

A new clinical algorithm developed at the University of Gothenburg can accurately identify highly aggressive forms of basal cell carcinoma. The algorithm uses a combination of clinical and dermoscopic images to distinguish between low-risk and high-risk tumors, allowing for more effective treatment and better patient outcomes.

SourceUniversity of Gothenburg·JournalDermatology Practical & Conceptual·TypeObservational study·DateJul 30, 2024

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed

The study reveals that the electric blue spots of the bluespotted ribbontail ray are produced by unique skin cells with a stable 3D arrangement of nanoscale spheres containing reflecting nanocrystals. The team believes this colouration provides camouflage benefits to the stingrays, allowing them to blend with their surroundings.

SourceSociety for Experimental Biology·JournalAdvanced Optical Materials·TypeExperimental study·DateJul 4, 2024

Researchers discover potential mole reversal therapy in rare condition

Researchers at Francis Crick Institute develop a new genetic therapy that silences mutated NRAS gene in cells with congenital melanocytic naevus syndrome (CMN), potentially reversing debilitating giant moles. The treatment has shown promising results in mice and could be used to reduce cancer risk in affected children and adults.

SourceThe Francis Crick Institute·JournalJournal of Investigative Dermatology·DateJun 17, 2024

How targeted nutrients can fight cancer

Researchers discovered a new way to effectively treat melanoma using nutrients to reactivate suppressed metabolic pathways in cancer cells. The innovative treatment, involving tyrosine nanomicelles, showed promising results in mice and lab-derived human cells, inhibiting tumour growth and reducing glycolysis.

SourceUniversity of Technology Sydney·JournalNature Nanotechnology·TypeExperimental study·DateJun 17, 2024

How aging clocks tick

Scientists have discovered that aging clocks measure stochastic changes in cells, rather than damage accumulation. This finding suggests that aging can be predicted using the variation in cellular processes.

SourceUniversity of Cologne·JournalNature Aging·TypeData/statistical analysis·DateMay 9, 2024

Mass General Brigham researchers identify potential drivers of chronic allergic inflammation

Researchers at Mass General Brigham have identified Th2-multipotent progenitor (Th2-MPP) cells, which may play a crucial role in sustaining type 2 inflammation and contribute to disease symptoms. These findings provide potential targets for therapeutic interventions and lay the groundwork for future disease-modifying approaches.

SourceMass General Brigham·JournalNature Immunology·TypeExperimental study·DateApr 30, 2024

It takes two to TANGO: New strategy to tackle fibrosis and scarring

Researchers developed a new experimental strategy to tackle scarring and fibrosis by releasing enough collagen to prevent tissue damage while protecting it from excessive amounts. The strategy, which uses molecules known as peptides to block the export of collagen from cells, shows promise in treating conditions such as scleroderma.

SourceCenter for Genomic Regulation·JournalNature Communications·TypeExperimental study·DateApr 24, 2024

Mosaics of predisposition cause skin disease

Researchers at Kobe University discovered a new gene, FDFT1, responsible for porokeratosis by identifying epigenetic silencing. Patients with localized lesions didn't have inherited damaged copies, leading to a hypothesis that epigenetic changes are the first hit. The findings have implications for treatment and counseling.

SourceKobe University·JournalThe American Journal of Human Genetics·TypeObservational study·DateApr 22, 2024

Chinese Medical Journal review article highlights the potential and promise of CAR-T cell therapy in autoimmune diseases

Researchers have identified CAR-T cell therapy as a potential treatment for autoimmune diseases such as rheumatoid arthritis, SLE, and type 1 Diabetes Mellitus. Early studies have shown promising results in reducing disease activity and improving patients' quality of life, but long-term data on safety and efficacy is limited.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateApr 22, 2024

NTU Singapore scientists grow ‘mini kidneys,’ revealing new insights into metabolic defects and potential therapy for polycystic kidney disease

Researchers at NTU Singapore successfully grew 'mini kidneys' in the lab, grafted them into live mice, and found a potential treatment for polycystic kidney disease by boosting autophagy. The study suggests that minoxidil could be used to reduce cysts in the novel mouse model.

SourceNanyang Technological University·JournalCell Stem Cell·TypeExperimental study·DateApr 8, 2024

Researchers led by NTU Singapore and the University of Toulouse discover how our body's immune response to bacterial infections could be ‘hurting’ us

Researchers from NTU Singapore and the University of Toulouse discovered a link between ionophores, cellular ion balance, and inflammation. The study found that cells trigger an immune response when potassium ions fall below a certain level, releasing pro-inflammatory molecules.

SourceNanyang Technological University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 19, 2024

Terahertz biosensor detects skin cancer with remarkable accuracy, ushering in new era of early detection

A new terahertz biosensor has been developed to detect skin cancer with exceptional sensitivity, leveraging the unique properties of THz waves. The device analyzes a combination of parameters to provide a richer picture of tissue, allowing for accurate differentiation between healthy and cancerous cells.

SourceQueen Mary University of London·JournalIEEE Transactions on Biomedical Engineering·DateFeb 20, 2024

Small RNAs take on the big task of helping skin wounds heal better and faster with minimal scarring

Researchers discovered that microRNA-29 can restore normal skin structure rather than producing a scar, promoting faster and more efficient wound healing. The release of microRNA-29 targets, particularly LAMC2, is crucial in this process, suggesting a potential new approach for treating large-area or deep wounds.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeObservational study·DateFeb 1, 2024

New insights revealed on tissue-dependent roles of JAK signaling in inflammation

Researchers have gained a deeper understanding of the nuanced roles of JAK inhibitors in inflammation across various cell types and tissues. The study reveals that activating JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, which suppresses lung inflammation.

Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

Researchers discovered distinct mechanisms controlling different types of immune cells and found a way to selectively eliminate 'problematic' cells driving autoimmune disorders. This breakthrough offers precise targets for potential treatment strategies, potentially revolutionizing the way we treat skin conditions.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalScience·TypeExperimental study·DateNov 30, 2023

Reprogramming tissue mechanically

Researchers at PSI and ETH Zurich successfully transplanted mechanically reprogrammed fibroblasts into a model of old, damaged skin tissue, revealing that the tissue can be rejuvenated and injuries heal faster. The technique uses spatially confined conditions to erase functional errors accumulated by aged cells during the aging process.

SourcePaul Scherrer Institute·JournalAging Cell·DateNov 27, 2023

New clues to early development of schizophrenia

Researchers have discovered axonal dysregulation in the prenatal brain as a mediator of genetic risk for schizophrenia. The study used induced pluripotent stem cells and three-dimensional brain organoids to identify key genes involved, including CYFIP1, which is highly expressed in microglia.

SourceElsevier·JournalBiological Psychiatry·TypeExperimental study·DateOct 24, 2023

Time is right to develop a consensus Human Skin Cell Atlas, according to leading dermatology experts

A global team of experts outlines a roadmap for creating a comprehensive and inclusive reference work on human skin cell composition. The proposed Human Skin Cell Atlas will provide a standardized framework for semi-automated mapping of patient-specific changes in skin diseases, supporting personalized medicine.

SourceElsevier·JournalJournal of Investigative Dermatology·TypeSystematic review·DateAug 21, 2023